5, 2024 (HealthDay News) -- Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found
Similar findings have been observed Pan et al (2024), which noted significant differences between multiple GLP-1 medications compared with placebo for achieving greater than 5%, 10%, and even 15% weight loss
Its findings, published recently in the American Journal of Ophthalmology , revealed a notable correlation between semaglutide, the most commonly prescribed GLP-1 RA, and increased incidents of ischemic optic neuropathy, diabetic retinopathy and several other retinal and vitreous issues
Indigo Ag launched microbial seed treatment to combat soybean cyst nematode The EPA-registered bionematicide, biotrinsic Nemora FP, introduces a Pseudomonas oryzihabitans strain that colonises soybean roots and shoots, preventing soybean cyst nematode (SCN) eggs from hatching while maintaining nodulation and root health
Start your intake What OTC Products Actually Contain and How They Differ OTC weight-loss supplements claiming GLP-1 benefits typically contain fiber, herbal extracts, conjugated linoleic acid (CLA), or glucomannannone of which activate the GLP-1 receptor
Researchers analyzed electronic health record data from a pool of 288 randomly selected qualified participants